All News

The U.S. Food and Drug Administration has approved Iressa (gefitinib) for the frontline treatment of patients with metastatic non-small cell lung cancer that is positive for EGFR and has one of two additional mutations.

Today, regardless of diagnosis, you are a survivor.

It doesn't get any easier to say goodbye to a friend and it brings close the reality that though we are living better, and longer with advanced cancer, that there is still no cure.

Cancer survivors who hope to adopt children may face some extra obstacles, but a history of cancer isn't necessarily a dealbreaker, especially when an adoption takes place within the United States.

Even my own family doesn't get it, and I'm glad. Two-time cancer survivor describes an isolating, fear-of-recurrence moment.

As the Centers for Medicare & Medicaid Services is proposing to support patient- and family-centered care for Medicare beneficiaries by enabling them to discuss advance care planning with their providers.

Though having a high body mass index (BMI) is associated with a higher risk for colorectal cancer, patients who are thinner may not do as well after treatment for metastatic colorectal cancer (mCRC).

The Pancreatic Cancer Action Network offers webinars, where listeners can learn about various topics from the comfort of their homes.

The ability to choose a compassionate death helps me to live in the moment I have now.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.

Nancy Carpenter was FreeToBreathe's featured survivor of the month for April.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses how insurance appeals can help a patient get the care they need.

Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses how insurance appeals can help a patient get the care they need.

The hotspots were identified in the lower Mississippi Delta, west central region of Appalachia and northeastern North Carolina/southeastern Virginia.

Nausea and vomiting associated with anticancer therapies continue to be among patients' most troubling symptoms.

Chemo is a tough slog, but advice from others who have been there can help make it a bit easier.

Is this a hospital or have I stepped on the "wayback machine" with the dial set to 1970?

Rolling submission of a new drug application for rociletinib has been initiated for patients with EGFR T790M-positive metastatic NSCLC following prior treatment with an EGFR-targeted therapy.

The President's Cancer Panel is looking for ways to improve connected health for cancer patients. What are your recommendations?

Living on the top floor with cancer.

Breast cancer and melanoma survivor Barbara Tako introduces herself.

Does sugar cause cancer? Does sugar feed cancer?

Eleanor Miller, a nurse at the University of Pennsylvania, writes about considerations for a patient who is pregnant with a breast cancer diagnosis.

A single intravenous dose of EMEND for Injection was shown to be superior to placebo when either were combined with other anti-vomiting agents for protection against CINV in patients receiving moderately emetogenic chemotherapy.

If you would like to confidentially participate in an international registry that tracks the pregnancy outcomes and long-term health of women, and children of women diagnosed with cancer during pregnancy, please contact Elyce Cardonick.

Just as electronic health records revolutionized the healthcare industry for nurses and doctors, patient portals are giving patients new ways to access their healthcare information and communicate with members of their healthcare team.

Several key areas in the treatment of melanoma include the selection of appropriate immunotherapy regimens based on PD-L1 status and improvement of surgical practices.

Advances in molecular profiling technologies have made it easier to understand the molecular characteristics and clinical behavior of breast cancer.

CURE spoke with Bruce D. Cheson to gain a deeper understanding of adding the targeted therapy Gazyva to the chemotherapy Treanda for patients with Rituxan-refractory indolent non-Hodgkin lymphoma.